SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Martin Luther King Jr.

PatientMartin Luther King
Date of birth1990-01-15
IdentifiersMRN HR-ML001-SYN; SSN (made up) 000-01-4058
Document date2026-06-02
AuthorCornelius Ashby-Nwankwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Eight-week review of depression, sleep, smoking and home blood pressure. [S]

History of Present Illness

Dr. King returns three weeks after his preventive visit. The nurse telephone call planned two weeks after starting sertraline did not reach him because he was travelling; he took sertraline 50 mg daily, with nausea for a few days only. He has had six therapy sessions and keeps a fixed rising time; he now sleeps about six hours. He stopped smoking on his quit date two weeks ago, using varenicline, and has mild nausea after the morning dose and vivid dreams, but no change in mood; cravings come late at night when he writes. He has kept his day off on four of the past six weeks. His home blood pressure readings over seven days averaged 136/86. He has had no thoughts of harming himself. [S]

ElementDetail
Sertraline50 mg for five weeks; early nausea only
Missed callTwo-week nurse call did not reach him
SmokingStopped two weeks ago on varenicline; night cravings
Home blood pressureSeven-day average 136/86
SleepAbout six hours

Review of Systems

SystemResultFinding
ConstitutionalPositiveLess tired
RespiratoryNegativeMorning cough easing since he stopped smoking
GastrointestinalPositiveMild nausea after the morning varenicline dose
NeurologicalNegativeNo headaches
PsychiatricPositiveMood better; vivid dreams; PHQ-9 11; no suicidal ideation

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Varenicline 0.5 mg tablet, one by mouth once daily for 3 days, then twice daily for 4 daysonce daily for 3 days, then twice daily for 4 days, after foodOral route2026-05-12 to 2026-05-19completedS
Varenicline 1 mg tablet, one by mouth twice daily after foodtwice daily after foodOral route2026-05-19activeS
Sertraline 25 mg tablet, one by mouth each morning for one weekonce daily in the morningOral route2026-04-20 to 2026-04-27completedS
Sertraline 50 mg tablet, one by mouth each morningonce daily in the morningOral route2026-04-27activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-06-02Body height170cmS
2026-06-02Body weight84.6kgS
2026-06-02Body mass index (BMI) [Ratio]29.3kg/m2S
2026-06-02Systolic blood pressure134mm[Hg]S
2026-06-02Diastolic blood pressure86mm[Hg]S
2026-06-02Heart rate76/minS
2026-06-02Respiratory rate14/minS
2026-06-02Body temperature36.7CelS
2026-06-02Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-02Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]11{score}S
2026-06-02Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]7{score}S
2026-06-02Albumin/Creatinine [Mass Ratio] in Urine8mg/gBelow 30NormalS

Physical Exam

Vital signs recorded on 2026-06-02; see the Vital Signs section. [S]

SystemFinding
GeneralBlood pressure 134/86, pulse 76; weight 84.6 kg, BMI 29.3
EyesFundi: no hypertensive retinopathy
CardiovascularRegular rhythm; no murmur or added sounds
PsychiatricBrighter; reactive affect; no suicidal ideation

Problems

ProblemClinical statusVerificationCodeProvenance
Exhaustion, broken sleep and low mood for about two months, under sustained threats and a punishing schedule, after an admission for exhaustion and a respiratory infection six months ago; cause not established at intake: a depressive disorder, an adjustment disorder, PTSD, an insomnia disorder, thyroid disease and anemia to be assessed; psychiatry consultation requestedresolvedconfirmed R53.83S — Synthetic presenting problem anchored to his documented admission for exhaustion and the threats against him; superseded by the diagnoses at the second visit.
Major depressive disorder, single episode, moderate (DSM-5-TR), arising under chronic threat, surveillance and overwork; no suicidal ideation; PTSD not present on screening and interviewactiveconfirmed F32.1S — Synthetic modern diagnosis made at the psychiatry consultation, linked to his documented exhaustion and threats and to biographers' accounts of depression (R); not a claim that he was so diagnosed.
Insomnia disorder (DSM-5-TR), comorbid with depression: trouble falling and staying asleep at least four nights a week for over three months, with short sleep from late-night work and travelactiveconfirmed G47.00S — Synthetic modern diagnosis made at the psychiatry consultation.
Nicotine dependence, cigarettes: about a pack a day since his twenties, smoked out of public viewactiveconfirmed F17.210S — Synthetic modern problem anchored to the documented account of his heavy, hidden smoking.
Elevated blood pressure readings in the clinic (138/88 mmHg) without a diagnosis of hypertension; home monitoring to confirmresolvedconfirmed R03.0S — Synthetic presenting finding; superseded by the diagnosis at the six-week visit.
Healed stab wound of the left chest, repaired by thoracotomy seven years ago; occasional aching along the scar with coughing and in cold weather, without exertional or ischemic featuresactiveconfirmed Z87.828S — Synthetic modern problem anchored to his documented stabbing and chest surgery in 1958.
Stage 1 hypertension (2017 ACC/AHA), confirmed by home readings averaging 136/86 mmHg; no end-organ damage (normal ECG, urine albumin, kidney function and fundi); low estimated 10-year risk; lifestyle treatmentactiveconfirmed I10S — Synthetic modern diagnosis made at the eight-week visit; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyPHQ-9At least monthly during acute treatment; every 2 to 4 weeks in continuationCompleted today11, from 17 at intake
SurveyGAD-7Every 4 to 8 weeks during treatmentCompleted today7, from 11
SurveySuicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9)Every visitCompleted todayNo suicidal ideation; PHQ-9 item 9 scored 0; no mood change on varenicline. Safety plan reviewed
Medication safetySSRI tolerability check two weeks after starting2 weeks after starting and after each dose changeDeferredProtocol deviation: the nurse telephone call due two weeks after sertraline started did not reach him because he was travelling, and no second attempt was made. His tolerability and mood were checked at the preventive visit three weeks after starting, when he reported only brief nausea and no suicidal thoughts, so no harm resulted. Corrective action: calls are now booked through his office's travel schedule, with a second attempt within two days
Medication safetyVarenicline neuropsychiatric and adverse-effect reviewWeekly by quitline for the first weeks, and every visitCompleted todayMild nausea and vivid dreams; no agitation, low mood or unusual thoughts
Self-managementSmoking status after the quit dateEvery visitCompleted todaySmoke-free for two weeks by his report
SurveyInsomnia Severity Index and sleep diaryEvery visit during CBT for insomniaCompleted todayInsomnia Severity Index 13; about six hours a night (score in the notes; no LOINC code used)
ExaminationOut-of-office blood pressure to confirm the diagnosisBefore diagnosis and when treatment changesCompleted todaySeven-day home average 136/86 on a validated arm monitor
ExaminationOffice blood pressure, weight and BMIEvery visitCompleted today134/86 mmHg; weight 84.6 kg, BMI 29.3
LaboratoryUrine albumin-to-creatinine ratioAt diagnosis, then yearlyCompleted today8 mg/g, normal
LaboratoryBasic metabolic panel, TSH, glucose or A1c, and lipids at diagnosisAt diagnosis, then yearlyUp to dateDrawn at intake eight weeks ago: all normal except LDL 142 mg/dL
Imaging12-lead ECG at diagnosisBaselineUp to dateNormal at intake
ExaminationFundoscopic examinationAt diagnosis, then yearlyCompleted todayNo hypertensive retinopathy
Survey10-year cardiovascular riskYearlyCompleted todayLow by the PREVENT equations; the Pooled Cohort Equations do not apply under 40
Self-managementSustainable work plan: a day off each week, two speeches a day at most, sleep window keptEvery visitCompleted todayDay off kept on four of six weeks; two speeches a day at most on most days

Goal progress:

Guideline basis: Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders, hypertension and hyperlipidemia monographs (2026); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES) (2016); 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017); Development and Validation of the American Heart Association's PREVENT Equations (2024)

Follow-up: Home blood pressure for a week before the next visit. Review in six weeks. Next scheduled visit 2026-07-14: fourteen-week review: mood, sleep, varenicline, blood pressure and the work plan. [S]